Population variation in linkage disequilibrium across the COMT gene considering promoter region and coding region variation

Human Genetics

Volumn 111, Issue 6, 2002, Pages 521-537

  DeMille, Mellissa M C ^a   Kidd, Judith ^a   Ruggeri, Valeria ^a   Palmatier, Meg A ^a   Goldman, David ^b   Odunsi, Adekunle ^c   Okonofua, Friday ^d   Grigorenko, Elena ^e   Schulz, Leslie O ^f   Bonne Tamir, Betsheva ^g   Lu, Ru Band ^h   Parnas, Josef ⁱ   Pakstis, Andrew J ^a   Kidd, Kenneth K ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

^d UNIVERSITY OF BENIN   (Nigeria)

^e YALE UNIVERSITY   (United States)

^f UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

^g TEL AVIV UNIVERSITY   (Israel)

^h TRI SERVICE GENERAL HOSPITAL   (Taiwan)

ⁱ UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL METHYLTRANSFERASE;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CHROMOSOME 22; CONTROLLED STUDY; ENZYME ACTIVITY; EXON; GENE; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HAPLOTYPE; HUMAN; MENTAL DISEASE; POPULATION GENETICS; PREDICTION; PRIORITY JOURNAL; PROBABILITY; PROMOTER REGION; PROTEIN DEGRADATION; RELIABILITY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

BASE SEQUENCE; CATECHOL O-METHYLTRANSFERASE; DNA PRIMERS; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; PROMOTER REGIONS (GENETICS); VARIATION (GENETICS);

EID: 0036941355     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00439-002-0809-0     Document Type: Article

References (31)

1. Anderson MA, Gusella JF (1984) Use of cyclosporin A in establishing Epstein-Barr virus-transformed human lymphoblastoid cell lines. In Vitro 20:856-858
2. Bertocci B, Miggiano V, Da Prada M, Dembic Z, Lahm HW, Malherbe P (1991) Human catechol-O-methyltransferase: Cloning and expression of the members-associated form. Proc Natl Acad Sci USA 88:1416-1420
3. Cargill M, Altshuler D, Ireland J, Sklar P, Ardlie K, Patil N, Shaw N, Lane CR, Lim EP, Kalyanaraman N, Nemesh J, Ziaugra L, Friedland L, Rolfe A, Warrington J, Lipshutz R, Daley GQ, Lander ES (1999) Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet 22:231-238
4. Castiglione CM, Deinard AS, Speed WC, Sirugo G, Rosenbaum HC, Zhang Y, Grandy DK, Grigorenko EL, Bonne-Tamir B, Pakstis AJ, et al. (1995) Evolution of haplotypes at the DRD2 locus. Am J Hum Genet 57:1445-1456
5. Chen CH, Lee YR, Liu MY, Wei FC, Koong FJ, Hwu HG, Hsiao KJ (1996) Identification of a BglI polymorphism of catechnol-O-methyltransferase (COMT) gene, and association study with schizophrenia. Am J Med Genet 67:556-559
6. Cooper JR, Bloom FE, Roth RH (1996) The Biochemical Basis of Neuropharmacology. Oxford, New York
7. Devlin B, Risch N (1995) A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics 29:311-322
8. Hawley ME, Kidd KK (1995) HAPLO: A program using the EM algorithm to estimate the frequencies of multi-site haplotypes. J Hered 86:409-411
9. Iyengar S, Seaman M, Deinard AS, Rosenbaum HC, Sirugo G, Castiglione CM, Kidd JR, Kidd KK (1998) Analysis of cross species polymerase chain reaction products to infer the ancestral state of human polymorphisms. DNA Seq 8:317-327
10. Karayiorgou M, Gogos JA, Galke BL, Wolyniec PS, Nestadt G, Antonarakis SE, Kazazian HH, Housman DE, Pulver AE (1998) Identification of sequence variants and analysis of the role of the catechol-O-methyl-transferase gene in schizophrenia susceptibility. Biol Psych 43:425-431
11. Karoum F, Chrapusta SJ, Egan MF (1994) 3-Methoxytyramine is the major metabolite of released dopamine in the rate frontal cortex: Reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model. J Neurochem 63:972-979
12. Kidd JR, Pakstis AJ, Zhao H, Lu RB, Okonofua FE, Odunsi A, Grigorenko E, Tamir BB, Friedlaender J, Schulz LO, Parnas J, Kidd KK (2000) Haplotypes and linkage disequilibrium at the phenylalanine hydroxylase locus, PAH, in a global representation of populations. Am J Hum Genet 66:1882-1899
13. Kidd KK, Morar B, Castiglione CM, Zhao H, Pakstis AJ, Speed WC, Bonne-Tamir B, Lu RB, Goldman D, Lee C, Nam YS, Grandy DK, Jenkins T, Kidd JR (1998) A global survey of haplotype frequencies and linkage disequilibrium at the DRD2 locus. Hum Genet 103:211-227
14. Lachman HM, Papolos SF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM (1996) Human catechol-O-methyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6:243-250
15. Lewontin RC (1964) The interaction of selection and linkage. I. General considerations: Heterotic models. Genetics 49:49-67
16. Li T, Ball D, Zhao J, Murray RM, Liu X, Sham PC, Collier DA (2000) Family-based linkage disequilibrium mapping using SNP marker haplotypes: Application to a potential locus for schizophrenia at chromosome 22q11. Mol Psych 5:77-84
17. Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Melen K, Julkunen I, Taskinen J (1995) Kinetics of human soluble and membrane-bound catechol O-methyltransferase: A revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 34:4202-4210
18. Mannisto PT, Kaakkola S (1999) Catechol-O-methyltransferase (COMT): Biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol Rev 51:593-628
19. Murphy KC, Jones LA, Owen MJ (1999) High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry 56:940-945
20. Osier M, Pakstis AJ, Kidd JR, Lee JF, Yin SJ, Ko HC, Edenberg HJ, Lu RB, Kidd KK (1999) Linkage disequilibrium at the ADH2 and ADH3 loci and risk of alcoholism. Am J Hum Genet 64:1147-1157
21. Palmatier MA, Kang AM, Kidd KK (1999) Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles. Biol Psych 46:557-567
22. Reilly DK, Rivera Calimlim L, Van Dyke D (1980) Catechol-O-methyltransferase activity: A determinant of levodopa response. Clin Pharmacol Ther 28:278-286
23. Rivett AJ, Eddy BJ, Roth JA (1982) Contribution of sulfate conjugation, deamination, and O-methylation to metabolism of dopamine and norepinephrine in human brain. J Neurochem 39:1009-1016
24. Rivett AJ, Francis A, Roth JA (1983) Distinct cellular localization of membrane-bound and soluble forms of catechol-O-methyltransferase in brain. J Neurochem 40:215-219
25. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, New York
26. Tenhunen J, Heikkila P, Alanko A, Heinonen E, Akkila J, Ulmanen I (1999) Soluble and membrane-bound catechol-O-methyltransferase in normal and malignant mammary gland. Cancer Lett 144:75-84
27. Tenhunen J, Salminen M, Lundstrom K, Kiviluoto T, Savolainen R, Ulmanen I (1994) Genomic organization of the human catechol O-methyltransferase gene and its expression from two distinct promoters. Eur J Biochem 223:1049-1059
28. Tishkoff SA, Goldman A, Calafell F, Speed WC, Deinard AS, Bonne-Tamir B, Kidd KK (1998) A global haplotype analysis of the myotonic dystrophy locus: Implications for the evolution of modern humans and for the origin of myotonic dystrophy mutations. Am J Hum Genet 62:1389-1402
29. Weir BS (1996) Genetic Data Analysis II. Sinauer, Sunderland, Massachusetts
30. Xie T, Ho SL, Ramsden D (1999) Characterization and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription. Mol Pharmacol 56:31-38
31. Zhao H, Pakstis AJ, Kidd JR, Kidd KK (1999) Assessing linkage disequilibrium in a complex genetic system. I. Overall deviation from random association. Ann Hum Genet 63:167-179